This led to the development of the so called Immunoscore assay to qualify and quantify the local host immune reaction to cancer cells, based on the numeration of two lymphocyte populations (CD3+ T cells and CD8+ cytotoxic T cells), both in the core of the tumor (TC) and in the invasive margin. Here, CD8A is linked to neoplasm.